Display Settings:

Format

Send to:

Choose Destination
    Front Biosci (Elite Ed). 2009 Jun 1;1:115-22.

    Signaling in fibrosis: targeting the TGF beta, endothelin-1 and CCN2 axis in scleroderma.

    Source

    CIHR Group in Skeletal Development and Remodeling, Division of Oral Biology, Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, University of Western Ontario, London ON, Canada. Andrew.Leask@schulich.uwo.ca

    Abstract

    Fibrosis affects organs such as the skin, liver, kidney and lung and is a cause of significant morbidity. There is no therapy for fibrosis. Recent significant molecular insights into the signaling underlying fibrosis have been made. Transforming growth factor beta (TGF beta) signaling is a major contributor to fibrogenesis. The signaling mechanisms through which TGF beta induces fibrogenic responses have been under intense scrutiny. Moreover, the potent pro-fibrotic proteins endothelin-1 (ET-1) and CCN2 (connective tissue growth factor, CTGF) are believed to play an essential role in this process as downstream regulators or co-factors of TGF beta signaling. This review summarizes these recent crucial observations with emphasis on the disease scleroderma.

    PMID:
    19482630
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Frontiers in Bioscience

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk